Clinical Trial Update: A Study of Auxora in Patients With Severe COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 results for Auxora in patients with severe COVID-19 pneumonia have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Auxora

Snippet

Sponsor: CalciMedica, Inc. | Conditions: Pneumonia | Phase 2 | Status: COMPLETED | Results posted: 2025-08-20